Pfizer CEO Announces Omicron Vaccine to be Ready in March
Pfizer is aiming to have a COVID-19 vaccine that specifically targets the Omicron variant to be ready in March, the chief executive officer (CEO) said on Jan. 10. Pfizer CEO …
Pfizer is aiming to have a COVID-19 vaccine that specifically targets the Omicron variant to be ready in March, the chief executive officer (CEO) said on Jan. 10. Pfizer CEO …
Surgeons in the United States successfully transplanted a heart from a genetically-modified pig to a human being for the first time. David Bennett, 57, received the pig heart in an …
Hong Kong researchers found that Sinovac Biotech, one of the most widely used vaccines worldwide, does not provide sufficient antibodies to neutralize the Omicron variant. A statement from a team …
Novavax has submitted an authorization filing for its COVID-19 vaccine in the United Kingdom, the biotechnology company announced on Oct. 27. Novavax said that it has completed its rolling regulatory …
The United States Food and Drug Administration (FDA) has authorized the use of Moderna and Johnson & Johnson COVID-19 booster shots. The FDA announced on Oct. 20 that a single …
The Centers for Disease Control and Prevention (CDC) recommended the Pfizer and Moderna COVID-19 vaccines be preferred for adults over the Johnson & Johnson (J&J) vaccine due to rare blood …
The United States Food and Drug Administration (FDA) authorized on Dec. 8 the first drug for widespread use in preventing COVID-19 for people with weakened immune systems. The FDA issued …
The European Commission has approved on Nov. 10 a deal with French vaccine company Valneva to supply up to 60 million doses of its COVID-19 vaccine candidate over the next …
Canada has authorized on Nov. 9 a booster dose of the Pfizer-BioNTech COVID-19 for adults aged 18 and older. The booster shot is identical to the regular Pfizer-BioNTech COVID-19 and …
The drugs regulator of the European Union (EU) approved on Oct. 25 the COVID-19 booster shot developed by Moderna. The European Medicines Agency (EMA) said that the Moderna COVID-19 booster …